<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="139554">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01905982</url>
  </required_header>
  <id_info>
    <org_study_id>RAT 2013</org_study_id>
    <secondary_id>KBerchtesgadener</secondary_id>
    <nct_id>NCT01905982</nct_id>
  </id_info>
  <brief_title>The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV; part2</brief_title>
  <official_title>The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy on Dyspnoea, Activity and Parasympathetic Activities in Patients With COPD III-IV</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinikum Berchtesgadener Land der Schön-Kliniken</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Osnabrueck</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Klinikum Berchtesgadener Land der Schön-Kliniken</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether different types of breathing therapies in
      patients with COPD III-IV decrease dyspnea, increase activity and have impact on
      parasympathetic activities.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in BORG-Scale</measure>
    <time_frame>Change from pre (minute 0) in Borg Scale and directly post intervention (minute 60)</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Instrument for self-reported dyspnea; modified BORG-scale ranges from 1 (no dyspnea) to 10 (maximum dyspnea)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in lung volume</measure>
    <time_frame>change from pre (minute0) in residual volume at post (minute 60)</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured by a bodyplethysmograph</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>activity</measure>
    <time_frame>48 h post</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured by Senswear</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>parasympathetic activities</measure>
    <time_frame>baseline and 60 minuts</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured via Biofeedback</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic Respiratory Questionnaire</measure>
    <time_frame>baseline and 60 minuts</time_frame>
    <safety_issue>No</safety_issue>
    <description>health related quality of life</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Conventional breathing therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>first: conventional breathing therapy, second: reflectory breathing therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reflectory breathing therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>first: Reflectory breathing therapy second:Conventional breathing therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>reflectory breathing therapy</intervention_name>
    <description>duration:60 minutes</description>
    <arm_group_label>Reflectory breathing therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional breathing therapy</intervention_name>
    <description>duration:60 minutes</description>
    <arm_group_label>Conventional breathing therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  impatient rehabilitation

          -  COPD (Gold stage III and IV)

        Exclusion Criteria:

          -  severe exacerbation in the last four weeks

          -  acute infections

          -  fever

          -  neuritides

          -  severe osteoporosis

          -  skin disease

          -  manic depression
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Klaus Kenn, Dr. med.</last_name>
    <role>Study Chair</role>
    <affiliation>Schön Klinik Berchtesgadener Land</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stella Seeberg</last_name>
    <role>Principal Investigator</role>
    <affiliation>Schön Klinik Berchtesgadener Land</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Schön Klinik Berchtesgadener Land</name>
      <address>
        <city>Schönau</city>
        <state>Bayern</state>
        <zip>83471</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 22, 2013</lastchanged_date>
  <firstreceived_date>July 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Klinikum Berchtesgadener Land der Schön-Kliniken</investigator_affiliation>
    <investigator_full_name>Klaus Kenn</investigator_full_name>
    <investigator_title>Head physician (department of pulmonology)</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
